Abstract
As endovascular technology has evolved, a number of randomized controlled trials (RCTs) comparing outcomes after transfemoral carotid artery stenting (TF-CAS) versus the “gold standard” of carotid endarterectomy (CEA) to treat carotid artery stenosis were designed. Herein, we provide an overview of the major RCTs investigating TF-CAS. We also provide a summary of the current societal recommendations for TF-CAS versus CEA and summarize the major patient characteristics that must be considered when planning the procedure. We discuss major technical considerations for optimizing results, including use of an embolic protection device, access considerations, and perioperative medications. Finally, throughout the chapter, we review the evolving role of transcarotid artery revascularization (TCAR) as an alternative to TF-CAS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Rutherford's Vascular Surgery and Endovascular Therapy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
